141 related articles for article (PubMed ID: 24576948)
1. The carbapenemase threat in the animal world: the wrong culprit.
Poirel L; Stephan R; Perreten V; Nordmann P
J Antimicrob Chemother; 2014 Jul; 69(7):2007-8. PubMed ID: 24576948
[No Abstract] [Full Text] [Related]
2. Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making?
Woodford N; Wareham DW; Guerra B; Teale C
J Antimicrob Chemother; 2014 Feb; 69(2):287-91. PubMed ID: 24092657
[TBL] [Abstract][Full Text] [Related]
3. Extended-spectrum beta-lactamase (ESBL)- and carbapenemase-producing Enterobacteriaceae in water sources in Lebanon.
Diab M; Hamze M; Bonnet R; Saras E; Madec JY; Haenni M
Vet Microbiol; 2018 Apr; 217():97-103. PubMed ID: 29615264
[TBL] [Abstract][Full Text] [Related]
4. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman.
Dortet L; Poirel L; Al Yaqoubi F; Nordmann P
Clin Microbiol Infect; 2012 May; 18(5):E144-8. PubMed ID: 22404169
[TBL] [Abstract][Full Text] [Related]
5. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
Savard P; Carroll KC; Wilson LE; Perl TM
Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078
[No Abstract] [Full Text] [Related]
6. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045
[TBL] [Abstract][Full Text] [Related]
7. Carbapenemase-producing Enterobacteriaceae: a call for action!
Nordmann P; Cornaglia G
Clin Microbiol Infect; 2012 May; 18(5):411-2. PubMed ID: 22507108
[No Abstract] [Full Text] [Related]
8. [Therapeutic options for carbapenemase-producing Enterobacteriaceae].
Salgado P; Gilsanz F; Maseda E
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():12-5. PubMed ID: 26365727
[TBL] [Abstract][Full Text] [Related]
9. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.
Nordmann P
Med Mal Infect; 2014 Feb; 44(2):51-6. PubMed ID: 24360201
[TBL] [Abstract][Full Text] [Related]
10. Comparison of phenotypic tests for detecting BKC-1-producing Enterobacteriaceae isolates.
Martins WM; Cordeiro-Moura JR; Ramos AC; Fehlberg LC; Nicoletti AG; Gales AC
Diagn Microbiol Infect Dis; 2016 Mar; 84(3):246-8. PubMed ID: 26744087
[TBL] [Abstract][Full Text] [Related]
11. Carbapenem-Resistant Enterobacteriaceae.
Iovleva A; Doi Y
Clin Lab Med; 2017 Jun; 37(2):303-315. PubMed ID: 28457352
[TBL] [Abstract][Full Text] [Related]
12. [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
Cercenado E
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():8-11. PubMed ID: 26365726
[TBL] [Abstract][Full Text] [Related]
13. The presence of blaKPC-mediated resistance in Enterobacteriaceae in Cairo University hospitals in Egypt and its correlation with in vitro carbapenem susceptibility.
Helal SF; El-Rachidi NG; AbdulRahman EM; Hassan DM
J Chemother; 2014 Apr; 26(2):125-8. PubMed ID: 24592883
[No Abstract] [Full Text] [Related]
14. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
Tängdén T; Giske CG
J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628
[TBL] [Abstract][Full Text] [Related]
15. Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.
Rodríguez-Baño J; Cisneros JM; Gudiol C; Martínez JA
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():49-55. PubMed ID: 25542052
[TBL] [Abstract][Full Text] [Related]
16. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers.
Huang TD; Poirel L; Bogaerts P; Berhin C; Nordmann P; Glupczynski Y
J Antimicrob Chemother; 2014 Feb; 69(2):445-50. PubMed ID: 24055766
[TBL] [Abstract][Full Text] [Related]
17. [The threat of the carbapenemase-producing enterobacteriaceae in Spain: positioning report of the SEIMC study groups, GEIH and GEMARA].
Oteo J; Calbo E; Rodríguez-Baño J; Oliver A; Hornero A; Ruiz-Garbajosa P; Horcajada JP; Del Pozo JL; Riera M; Sierra R; Bou G; Salavert M
Enferm Infecc Microbiol Clin; 2014 Dec; 32(10):666-70. PubMed ID: 24767691
[TBL] [Abstract][Full Text] [Related]
18. Extended-spectrum beta-lactamases: implications for the clinical laboratory and therapy.
Harada S; Ishii Y; Yamaguchi K
Korean J Lab Med; 2008 Dec; 28(6):401-12. PubMed ID: 19127103
[TBL] [Abstract][Full Text] [Related]
19. Carbapenemase-producing Enterobacteriaceae: a 2-year surveillance in a hospital in Iaşi, Romania.
Braun SD; Dorneanu OS; Vremeră T; Reißig A; Monecke S; Ehricht R
Future Microbiol; 2016; 11(3):391-401. PubMed ID: 26974389
[TBL] [Abstract][Full Text] [Related]
20. Screening for carbapenemase-producing Enterobacteriaceae-issues for consideration.
Welfare W; Decraene V; Cleary P; Dodgson A; Puleston R;
J Infect; 2016 Feb; 72(2):260-2. PubMed ID: 26546853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
